Record Quarterly Revenue and Adjusted EBITDA
RadNet achieved a record quarterly revenue of $498.2 million, an 8.4% increase from the previous year. Adjusted EBITDA also reached a record $81.2 million, a 12.3% increase from last year.
Advanced Imaging Growth
Advanced imaging procedures increased to 27.5% of total procedures, up from 26.5% last year, with MRI, CT, and PET/CT showing significant growth. PET/CT procedures grew 22.4% on an aggregate basis.
Successful Implementation of TechLive
TechLive significantly contributed to a 42% decrease in MRI room closures in New York, leading to increased capacity and efficiency.
Digital Health Segment Expansion
Digital Health segment revenue increased by 30.9% to $20.7 million, driven by AI and radiology software revenue growth.
Positive Cash Position and Low Leverage
RadNet ended the quarter with $833 million in cash and a net debt to adjusted EBITDA ratio of 0.96, indicating strong liquidity and financial health.
Acquisition of iCAD and See-Mode Technologies
The acquisitions are expected to expand RadNet's capabilities in AI-powered imaging solutions, particularly in breast cancer screening and ultrasound imaging.